Sources | Names Used |
---|---|
CTRPv2 | sirolimus:bortezomib (250:1 mol/mol) |
PharmacoGx | sirolimus:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLAMF6 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | PRDX2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | BLK | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | ZNF296 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
mRNA | RPRD2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | LTBR | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-06 |
mRNA | CCDC126 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | OR13A1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | TMEM38A | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | MAPKAPK3 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |